Test Price
2,800 AED✅ Home Collection Available
EYA1 Gene Otofaciocervical Syndrome Genetic Test in UAE | 2,800 AED
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily 8 AM – 11 PM).
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The EYA1 gene NGS test detects pathogenic variants in the EYA1 gene responsible for otofaciocervical syndrome (branchiootorenal spectrum), aiding precise diagnosis and management. This test adheres to UAE regulatory standards, using next‑generation sequencing for unmatched accuracy and minimal turnaround.
| Feature | Our Test (NGS) | Closest Alternative (Sanger Sequencing) |
|---|---|---|
| Method | Next Generation Sequencing (NGS) | Sanger Sequencing |
| Coverage | Full gene, including non‑coding regions | Only selected coding exons |
| Diagnostic Sensitivity | 99.9% | ~85-90% |
| Turnaround Time | 3–4 Weeks | 5–8 Weeks |
Physician Insight & Safety Protocols
Lina Osama Zaki Quteineh (Consultant Medical Genetics, DHA Registration ID: 9294403) notes:
“As a DHA‑licensed genetic consultant, I emphasize that the EYA1 NGS test provides definitive molecular confirmation when clinical features suggest otofaciocervical syndrome. However, results must be interpreted within the full clinical context and genetic counseling. A negative result does not rule out other genetic causes, and follow‑up with a pediatrician or geneticist remains essential.”
Advisory: Medication Continuation
Do not discontinue or alter any prescribed medication before, during, or after sample collection without first consulting your primary care physician. The genetic test does not interact with medications, but your overall health plan should be discussed with your doctor.
Safety Exclusion Criteria & Emergency Red Flags
- Exclusion Criteria: Individuals under 18 years without parental/guardian consent; active skin infection or cellulitis at venipuncture site; severe coagulopathy (e.g., INR >2.0, platelets <30,000/μL) unless medically cleared. Pregnancy is not a contraindication but requires obstetrician approval.
- Emergency Red Flags: If after home blood collection you develop progressive swelling, severe pain, or signs of infection (redness, warmth, discharge), seek immediate emergency medical attention. Syncope or chest pain after the procedure also warrants urgent evaluation.
Patient FAQ & Clinical Guidance
1. What does the EYA1 genetic test diagnose and how is it performed?
This test analyses the EYA1 gene to detect mutations causing otofaciocervical syndrome using next‑generation sequencing. A small blood sample (or extracted DNA / FTA card) is collected via our VIP mobile phlebotomy service, and the DNA is sequenced in an ISO‑certified lab. Results identify pathogenic variants to confirm the clinical diagnosis.
2. How do I arrange the home blood collection service and what is the cost?
Our VIP mobile phlebotomy team collects your sample at your doorstep between 8 AM – 11 PM. The test costs 2,800 AED, inclusive of home collection, cold‑chain transport, sequencing, and a post‑test clinical guidance call. You can schedule via WhatsApp at +971 54 548 8731 and receive instant insurance billing verification.
3. Are my genetic data and results secure under UAE law?
All genetic data is encrypted and processed in compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Your sample and results are stored in a secure bio‑bank under strict access controls; no data is shared without your explicit consent.
UAE Regulatory & Data Privacy Adherence
All testing and data handling operations at DNA Labs UAE are fully compliant with UAE federal data protection and health information privacy laws. We adhere to:
- Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) – ensuring encrypted storage, restricted access, and explicit consent for any data sharing.
- Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields – governing the secure processing and transmission of electronic health records and genetic information.
Your genetic privacy is paramount. No personal or genetic data is transferred to third parties without your written authorization, in full alignment with UAE legal frameworks.
Clinical & Logistical Metadata
| Test Name | EYA1 Gene Otofaciocervical Syndrome Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Peripheral Blood, Extracted DNA, or FTA Card Sample |
| Methodology Used | Next Generation Sequencing (NGS) |
| ICD-10-CM Code | Q87.0, Q18.8, Z13.71 |
| LOINC Code | 77642-5 |
| DHA Facility License & Laboratory Address | DNA Labs UAE | DHA Facility License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians